Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1s/sα2s/s Mouse Model of High Affinity

Pauline V Marck1, Marco T Pessoa1, Yunhui Xu1

  • 1Marshall Institute for Interdisciplinary Research, Huntington, WV 25703, USA.

Insights

Endogenous cardiotonic steroids (CTS) stimulate physiological cardiac hypertrophy in mice by increasing Na/K-ATPase α1 sensitivity, leading to elevated reactive oxygen species (ROS) and altered gene expression without impairing cardiac function.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Endocrinology

Background:

  • Cardiotonic steroids (CTS) like ouabain and digoxin interact with Na/K-ATPase.
  • Pharmacological CTS concentrations inhibit Na/K-ATPase, while endogenous levels may stimulate cardiac myocyte growth via Na/K-ATPase and ROS signaling.

Purpose of the Study:

  • To investigate the in vivo effects of endogenous CTS concentrations on cardiac structure and function.
  • To explore the role of Na/K-ATPase α1 affinity for CTS in physiological cardiac hypertrophy.

Main Methods:

  • Comparison of mice with naturally resistant Na/K-ATPase α1 versus those engineered for high CTS affinity.
  • Analysis of cardiac protein content, Na/K-ATPase activity, ROS markers (carbonylated protein), cardiac structure (heart-weight-to-tibia-length ratio, myocyte size), cardiac function (echocardiography), gene expression (RNA sequencing), and fibrosis response to angiotensin-II challenge.

Main Results:

  • Increased Na/K-ATPase α1 sensitivity to CTS elevated cardiac ROS production and myocyte size.
  • A significant increase in heart-weight-to-tibia-length ratio was observed.
  • No changes in cardiac function, fibrosis, or fetal gene program re-expression were detected.
  • RNA sequencing revealed upregulated energy metabolism pathways and downregulated extracellular matrix organization pathways.

Conclusions:

  • Circulating CTS, Na/K-ATPase α1, and ROS are linked to physiological cardiac hypertrophy in mice.
  • Enhanced CTS sensitivity of Na/K-ATPase α1 promotes adaptive cardiac remodeling.
  • The findings suggest a novel mechanism for regulating cardiac mass under physiological conditions.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
914
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
168
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.0K